{"text_format":"3","workbook":"xls","n_sheets":3,"sheets":["Sheet1","Sheet2","Sheet3"],"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Sheet1","index":0,"n_rows":27,"n_cols":6,"rows_kept":27,"merged":[[0,0,0,5],[26,0,26,5]],"flags":["formulas_cached_only"]}
["Table S6. Frequency of Copy Number Variation (CNV) States for MMP3, CYP3A4, and CYP3A43 Genes Across Different Ovarian Cancer Cohorts"]
["Research Cohort (n=patients)","Gene Alteration (%)","Mutated (%)","Amp (%)","Homdel (%)","Multiple (%)"]
["MMP3, CYP3A4, and CYP3A43:"]
["Ovarian Serous Cystadenocarcinoma (TCGA, Firehose Legacy; n=584)",11.82,"0.17 (1/584)","10.79 (63/584)","0.68 (4/584)","0.17 (1/584)"]
["Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas; n=584)",7.36,"0.51 (3/584)","6.51 (38/584)","0.17 (1/584)","0.17 (1/584)"]
["Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011; n=489)",5.93,"0.20 (1/489)","5.52 (27/489)","N/A","0.20 (1/489)"]
["Ovarian Cancer (CPTAC, GDC; n=96)",5.21,"5.21 (5/96)","N/A","N/A","N/A"]
["High-Grade Serous Ovarian Carcinoma (TCGA, GDC; n=567)",4.06,"0.35 (2/567)","3.53 (20/567)","N/A","0.18 (1/567)"]
["MMP3:"]
["Ovarian Serous Cystadenocarcinoma (TCGA, Firehose Legacy; n=584)",7.71,"0.17 (1/584)","6.85 (40/584)","0.68 (4/584)","N/A"]
["Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas; n=584)",4.45,"0.17 (1/584)","4.11 (24/584)","0.17 (1/584)","N/A"]
["Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011; n=489)",4.09,"0.20 (1/489)","3.89 (19/489)","N/A","N/A"]
["High-Grade Serous Ovarian Carcinoma (TCGA, GDC; n=567)",2.29,"0.35 (2/567)","1.94 (11/567)","N/A","N/A"]
["Ovarian Cancer (CPTAC, GDC; n=96)",1.04,"1.04 (1/96)","N/A","N/A","N/A"]
["CYP3A4:"]
["Ovarian Serous Cystadenocarcinoma (TCGA, Firehose Legacy; n=584)",4.62,"N/A","4.62 (27/584)","N/A","N/A"]
["Ovarian Cancer (CPTAC, GDC; n=96)",3.13,"3.13 (3/96)","N/A","N/A","N/A"]
["Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas; n=584)",2.4,"N/A","2.40 (14/584)","N/A","N/A"]
["High-Grade Serous Ovarian Carcinoma (TCGA, GDC; n=567)",1.94,"N/A","1.94 (11/567)","N/A","N/A"]
["Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011; n=489)",1.84,"N/A","1.84 (9/489)","N/A","N/A"]
["CYP3A43:"]
["Ovarian Serous Cystadenocarcinoma (TCGA, Firehose Legacy; n=584)",4.97,"0.17 (1/584)","4.79 (28/584)","N/A","N/A"]
["Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas; n=584)",3.25,"0.51 (3/584)","2.74 (16/584)","N/A","N/A"]
["Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011; n=489)",2.45,"0.20 (1/489)","2.25 (11/489)","N/A","N/A"]
["High-Grade Serous Ovarian Carcinoma (TCGA, GDC; n=567)",2.12,"0.18 (1/567)","1.94 (11/567)","N/A","N/A"]
["Ovarian Cancer (CPTAC, GDC; n=96)",1.04,"1.04 (1/96)","N/A","N/A","N/A"]
["Note: N/A indicates that the data was not reported for this specific alteration type in the corresponding cohort or the alteration was not detected. Values in parentheses represent the number of patients with the alteration / total number of patients in the cohort."]

{"sheet":"Sheet2","index":1,"n_rows":0,"n_cols":0,"rows_kept":0,"flags":["formulas_cached_only"]}

{"sheet":"Sheet3","index":2,"n_rows":0,"n_cols":0,"rows_kept":0,"flags":["formulas_cached_only"]}